AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26372387 — intervention group
Group type: EXPERIMENTAL
Intervention: Darunavir/ritonavir monotherapy (DRV/r) 800/100 mg once daily
Number of subjects: 273
Study 26372387 — intervention group
Group type: COMPARATOR
Intervention: Darunavir/ritonavir with two nucleoside analogues (triple therapy)
Number of subjects: 273
Study 24231879 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 50
Study 24231879 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorcaserin
Number of subjects: 50
Study 24231879 — intervention group
Group type: EXPERIMENTAL
Intervention: Top-dose phentermine plus topiramate-extended release (15/92 mg)
Number of subjects: 50
Study 24231879 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 21932023 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate placement of OsseoSpeed implants in fresh extraction sockets
Number of subjects: 20
Study 21932023 — intervention group
Group type: COMPARATOR
Intervention: Immediate placement of OsseoSpeed implants in healed edentulous ridges
Number of subjects: 20
Study 19053977 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 306
Study 19053977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 306
Study 17530036 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 200 mg single dose
Number of subjects: 20
Study 17530036 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 400 mg single dose
Number of subjects: 20
Study 17530036 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 400 mg b.i.d. for 10 days
Number of subjects: 20
Study 17530036 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 400 mg t.i.d. for 10 days
Number of subjects: 20
Study 17530036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 17530036 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 400 mg b.i.d. and t.i.d.
Number of subjects: 20
Study 17530036 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 400 mg t.i.d.
Number of subjects: 20
Study 11704172 — intervention group
Group type: EXPERIMENTAL
Intervention: ORTHO EVRA/EVRA (transdermal contraceptive system delivering norelgestromin 150 microg and ethinyl estradiol 20 microg daily)
Number of subjects: 1672
Study 9600581 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (3 x 5 mg)
Number of subjects: 125
Study 9600581 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (3 x 1 mg)
Number of subjects: 125
Study 9600581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 7598758 — intervention group
Group type: EXPERIMENTAL
Intervention: Major depressive disorder (MDD)
Number of subjects: 362
Study 7598758 — intervention group
Group type: EXPERIMENTAL
Intervention: Major depressive disorder (MDD) episode duration
Number of subjects: 362
Study 7598758 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrence of major depressive disorder (MDD)
Number of subjects: 362
Study 2760359 — intervention group
Group type: EXPERIMENTAL
Intervention: Smallpox needle (SN)
Number of subjects: 15
Study 2760359 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifurcated needle (BN)
Number of subjects: 15
Study 2760359 — intervention group
Group type: EXPERIMENTAL
Intervention: Greer 'pen' (GP)
Number of subjects: 15
Study 2760359 — intervention group
Group type: EXPERIMENTAL
Intervention: Morrow‐Brown needle (MB)
Number of subjects: 15
Study 2760359 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi‐Test (MT)
Number of subjects: 15
Study 2760359 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood lancet
Number of subjects: 15
Study 789411 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide
Number of subjects: 6
Study 789411 — intervention group
Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 6
Study 31506077 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week dietary intervention promoting weekly consumption of 2.5 cups of cruciferous vegetables and 3.5 cups of green leafy vegetables
Number of subjects: 24
Study 31506077 — intervention group
Group type: EXPERIMENTAL
Intervention: One-on-one telephone counseling from a registered dietitian nutritionist
Number of subjects: 24
Study 31506077 — intervention group
Group type: EXPERIMENTAL
Intervention: Study program evaluation
Number of subjects: 24
Study 28232390 — intervention group
Group type: EXPERIMENTAL
Intervention: 'Do not interrupt' bundled intervention (wearing a vest, strategies for diverting interruptions, clinician and patient education, reminders)
Number of subjects: 227
Study 28232390 — intervention group
Group type: COMPARATOR
Intervention: Control wards (blinded to the intervention)
Number of subjects: 227
Study 28232390 — intervention group
Group type: EXPERIMENTAL
Intervention: Poststudy survey of intervention ward nurses
Number of subjects: 227
Study 25742287 — intervention group
Group type: EXPERIMENTAL
Intervention: H-HOPE intervention
Number of subjects: 182
Study 25742287 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 182
Study 23130655 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP plus 1% metformin gel
Number of subjects: 50
Study 23130655 — intervention group
Group type: COMPARATOR
Intervention: SRP plus placebo
Number of subjects: 50
Study 20820795 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole
Number of subjects: 261
Study 20820795 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 261
Study 19168154 — intervention group
Group type: EXPERIMENTAL
Intervention: AFI
Number of subjects: 100
Study 19168154 — intervention group
Group type: EXPERIMENTAL
Intervention: HRE
Number of subjects: 100
Study 19168154 — intervention group
Group type: COMPARATOR
Intervention: NBI
Number of subjects: 100
Study 16715639 — intervention group
Group type: EXPERIMENTAL
Intervention: Six week school skills programme
Number of subjects: 13
Study 16715639 — intervention group
Group type: COMPARATOR
Intervention: Regular schooling
Number of subjects: 13
Study 15084614 — intervention group
Group type: EXPERIMENTAL
Intervention: ATRA and chemotherapy (CT)
Number of subjects: 31
Study 15084614 — intervention group
Group type: COMPARATOR
Intervention: ATRA and chemotherapy (CT) for maintenance
Number of subjects: 31
Study 11437888 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (320 mg administered three times at 4-hour intervals)
Number of subjects: 31
Study 11437888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 11437888 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 31
Study 9710890 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-1 receptor antagonist (IL-1ra)
Number of subjects: 0
Study 7935224 — intervention group
Group type: EXPERIMENTAL
Intervention: GTN (0.1%, solved in NaCl; dose 2.8 +/- 0.5 mg/h)
Number of subjects: 22
Study 7935224 — intervention group
Group type: EXPERIMENTAL
Intervention: ISDN (0.1%, solved in NaCl; dose 4.8 +/- 0.8 mg/h)
Number of subjects: 22
Study 7935224 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl solution, 3 ml/h)
Number of subjects: 22
Study 3428378 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-site intradermal (i.d.) PCEC regimen
Number of subjects: 0
Study 3428378 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-site intradermal (i.d.) PCEC regimen
Number of subjects: 0
Study 3428378 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-site intramuscular (i.m.) PCEC regimen
Number of subjects: 0
Study 3428378 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous regimen using suckling mouse brain (SMB) rabies vaccine
Number of subjects: 0
Study 3428378 — intervention group
Group type: EXPERIMENTAL
Intervention: Human rabies immune globulin therapy
Number of subjects: 0
Study 3428378 — intervention group
Group type: EXPERIMENTAL
Intervention: Equine antirabies serum (EARS)
Number of subjects: 0
Study 3428378 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized reactions related to EARS
Number of subjects: 0
Study 29778486 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative long-course chemoradiotherapy (CRT)
Number of subjects: 0
Study 29778486 — intervention group
Group type: COMPARATOR
Intervention: Preoperative long-course radiotherapy alone (RT)
Number of subjects: 0
Study 26867075 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral treatment for reducing hostility (12-week program)
Number of subjects: 158
Study 26867075 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 158
Study 24726294 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 150 mg/kg IV over 20 hours
Number of subjects: 10
Study 24726294 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of N-acetylcysteine (NAC) and infliximab (5 mg/kg IV as a single 2-hour administration)
Number of subjects: 10
Study 24726294 — intervention group
Group type: COMPARATOR
Intervention: N-acetylcysteine (NAC) or NAC with infliximab
Number of subjects: 10
Study 22806235 — intervention group
Group type: EXPERIMENTAL
Intervention: Note-taking intervention group
Number of subjects: 126
Study 22806235 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard teaching)
Number of subjects: 126
Study 22806235 — intervention group
Group type: EXPERIMENTAL
Intervention: Note-taking intervention group (first-time mothers)
Number of subjects: 126
Study 22806235 — intervention group
Group type: COMPARATOR
Intervention: Control group (first-time mothers)
Number of subjects: 126
Study 20459775 — intervention group
Group type: EXPERIMENTAL
Intervention: sirolimus-containing immunosuppression
Number of subjects: 0
Study 20459775 — intervention group
Group type: COMPARATOR
Intervention: mTOR-inhibitor-free immunosuppression
Number of subjects: 0
Study 19641760 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbst appliance (group 1, 12 individuals, average age 12 years 4 months, treated for 8.7 months)
Number of subjects: 43
Study 19641760 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular protraction appliance (group 2, 15 individuals, average age 13 years 2 months, treated for 8.3 months)
Number of subjects: 43
Study 19641760 — intervention group
Group type: COMPARATOR
Intervention: Control group (group 3, 16 individuals, average age 10 years 4 months, no treatment for 10 months)
Number of subjects: 43
Study 15639301 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 12748432 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative subfascial infusion with 0.5% bupivacaine at 2 ml per hour for 48 hours
Number of subjects: 44
Study 12748432 — intervention group
Group type: COMPARATOR
Intervention: Oral analgesics alone (nonpump group)
Number of subjects: 44
Study 12748432 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative subfascial infusion with 0.5% bupivacaine
Number of subjects: 44
Study 10654982 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate aqueous nasal spray (MFNS) 100 microg QD
Number of subjects: 98
Study 10654982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 10654982 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate aqueous nasal spray (MFNS)
Number of subjects: 98
Study 9049515 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cholesterol levels ≤ 160 mg/dl
Number of subjects: 595
Study 9049515 — intervention group
Group type: COMPARATOR
Intervention: Total cholesterol levels > 160 mg/dl (controls)
Number of subjects: 595
Study 8317655 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway
Number of subjects: 60
Study 8317655 — intervention group
Group type: COMPARATOR
Intervention: Tracheal intubation
Number of subjects: 60
Study 3719282 — intervention group
Group type: EXPERIMENTAL
Intervention: Video feedback training
Number of subjects: 36
Study 3719282 — intervention group
Group type: COMPARATOR
Intervention: Conventional teaching
Number of subjects: 36
Study 29656569 — intervention group
Group type: EXPERIMENTAL
Intervention: Small‐quantity lipid‐based nutrient supplements (SQ‐LNS)
Number of subjects: 0
Study 29656569 — intervention group
Group type: COMPARATOR
Intervention: Iron‐folic acid (IFA) capsules
Number of subjects: 0
Study 29656569 — intervention group
Group type: COMPARATOR
Intervention: Multiple micronutrient (MMN) capsules
Number of subjects: 0
Study 29656569 — intervention group
Group type: EXPERIMENTAL
Intervention: All supplements (SQ‐LNS, IFA, MMN)
Number of subjects: 0
Study 27653293 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP block with local anesthetics and dexamethasone
Number of subjects: 66
Study 27653293 — intervention group
Group type: EXPERIMENTAL
Intervention: PILA with dexamethasone
Number of subjects: 66
Study 27653293 — intervention group
Group type: COMPARATOR
Intervention: Control (no regional technique)
Number of subjects: 66
Study 27653293 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP block
Number of subjects: 66
Study 27653293 — intervention group
Group type: EXPERIMENTAL
Intervention: PILA
Number of subjects: 66
Study 27653293 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 66
Study 25424951 — intervention group
Group type: EXPERIMENTAL
Intervention: VaxiRab N
Number of subjects: 86
Study 25424951 — intervention group
Group type: COMPARATOR
Intervention: Rabipur
Number of subjects: 86
Study 23753114 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRHa trigger (0.5 mg buserelin) followed by a single bolus of 1.500 IU hCG
Number of subjects: 390
Study 23753114 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRHa trigger (0.5 mg buserelin) followed by two boluses of 1.500 IU hCG
Number of subjects: 390
Study 23753114 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRHa trigger with one bolus of 1.500 IU hCG
Number of subjects: 390
Study 23753114 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRHa trigger with two boluses of 1.500 IU hCG
Number of subjects: 390
Study 19170961 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained group (OC+)
Number of subjects: 28
Study 19170961 — intervention group
Group type: COMPARATOR
Intervention: Untrained group (OC+ and OC-)
Number of subjects: 28
Study 18707619 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin beta 30,000 IU once weekly
Number of subjects: 50
Study 18707619 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin beta 20,000 IU once weekly
Number of subjects: 50
Study 18707619 — intervention group
Group type: COMPARATOR
Intervention: Epoetin beta (both doses)
Number of subjects: 50
Study 16651750 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch 20 cm2 (TNP-20x1)
Number of subjects: 12
Study 16651750 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch 20 cm2 (TNP-20x2)
Number of subjects: 12
Study 16651750 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch 30 cm2 (TNP-30x1)
Number of subjects: 12
Study 16651750 — intervention group
Group type: COMPARATOR
Intervention: Cigarette smoking (12 cigarettes at 1 h intervals)
Number of subjects: 12
Study 14672298 — intervention group
Group type: EXPERIMENTAL
Intervention: Meat supplementation (60-85 g/d)
Number of subjects: 555
Study 14672298 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk supplementation (200-250 mL/d)
Number of subjects: 555
Study 14672298 — intervention group
Group type: COMPARATOR
Intervention: Energy supplementation (isocaloric with meat and milk, 240-300 kcal/d)
Number of subjects: 555
Study 14672298 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 555
Study 11204322 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) measurement in children with purulent meningitis
Number of subjects: 27
Study 11204322 — intervention group
Group type: COMPARATOR
Intervention: Procalcitonin (PCT) measurement in children with aseptic meningitis
Number of subjects: 27
Study 11204322 — intervention group
Group type: COMPARATOR
Intervention: Procalcitonin (PCT) measurement in healthy controls
Number of subjects: 27
Study 8611684 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL‐11 at 50 micrograms/kg
Number of subjects: 93
Study 8611684 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL‐11 at 25 micrograms/kg
Number of subjects: 93
Study 8611684 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 30891657 — intervention group
Group type: EXPERIMENTAL
Intervention: ICT (Inhibitory Control Training)
Number of subjects: 106
Study 30891657 — intervention group
Group type: COMPARATOR
Intervention: Sham (Control)
Number of subjects: 106
Study 30891657 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified ICT
Number of subjects: 106
Study 30891657 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-gamified ICT
Number of subjects: 106
Study 30285891 — intervention group
Group type: COMPARATOR
Intervention: Western medicine treatment for IBS (control group)
Number of subjects: 600
Study 26546105 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation (CRYO)
Number of subjects: 153
Study 26546105 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency (RF)
Number of subjects: 153
Study 26546105 — intervention group
Group type: EXPERIMENTAL
Intervention: Both RF and CRYO
Number of subjects: 153
Study 25542201 — intervention group
Group type: EXPERIMENTAL
Intervention: Actuated virtual keypad (AVK) system, 18 hour-long sessions (3x per week for 6 weeks)
Number of subjects: 14
Study 22350285 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonophoresis with SonoPrep® followed by EMLA® cream application
Number of subjects: 42
Study 22350285 — intervention group
Group type: COMPARATOR
Intervention: Sham sonophoresis followed by EMLA® cream application
Number of subjects: 42
Study 18337359 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive training program consisting of an exercise program of 15 minutes' duration 3 times a week, including 5 exercises for strength, flexibility, and coordination
Number of subjects: 1020
Study 18337359 — intervention group
Group type: COMPARATOR
Intervention: Placebo program consisting of 5 exercises for the upper body
Number of subjects: 1020
Study 18337359 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive training program
Number of subjects: 1020
Study 16600229 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic metroplasty including section of the cervical septum (Group A)
Number of subjects: 28
Study 16600229 — intervention group
Group type: COMPARATOR
Intervention: Hysteroscopic metroplasty with preservation of the cervical septum (Group B)
Number of subjects: 28
Study 14664421 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO 600 U/kg once weekly for three weeks plus iron supplementation
Number of subjects: 50
Study 14664421 — intervention group
Group type: COMPARATOR
Intervention: Iron supplementation only
Number of subjects: 50
Study 10833724 — intervention group
Group type: EXPERIMENTAL
Intervention: Figurative strategy (combining figures in unusual ways)
Number of subjects: 45
Study 10833724 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpretative strategy (looking for unusual meanings)
Number of subjects: 45
Study 10833724 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no strategy suggested)
Number of subjects: 45
Study 9425970 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-shot spinal anesthesia
Number of subjects: 40
Study 9425970 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous spinal anesthesia
Number of subjects: 40
Study 8409054 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 314
Study 8409054 — intervention group
Group type: COMPARATOR
Intervention: Bypass surgery
Number of subjects: 314
Study 8409054 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-bypassed segments
Number of subjects: 314
Study 8409054 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenosis-containing segments
Number of subjects: 314
Study 8409054 — intervention group
Group type: EXPERIMENTAL
Intervention: Segment occlusion
Number of subjects: 314
Study 8409054 — intervention group
Group type: EXPERIMENTAL
Intervention: Univariate and multivariate associations
Number of subjects: 314
Study 2980554 — intervention group
Group type: EXPERIMENTAL
Intervention: Iotrolan
Number of subjects: 1400
Study 2980554 — intervention group
Group type: COMPARATOR
Intervention: Metrizamide
Number of subjects: 1400
Study 2980554 — intervention group
Group type: COMPARATOR
Intervention: Iopamidol
Number of subjects: 1400
Study 2980554 — intervention group
Group type: COMPARATOR
Intervention: Iohexol
Number of subjects: 1400
Study 28967235 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-conferencing follow-up with urban-based rheumatologists and rural in-person physical therapist examiners
Number of subjects: 85
Study 28967235 — intervention group
Group type: COMPARATOR
Intervention: Traditional in-person rheumatology follow-up
Number of subjects: 85
Study 28967235 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 85
Study 27565651 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational receptor‐specific partial agonist drug
Number of subjects: 2
Study 27565651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 24519025 — intervention group
Group type: EXPERIMENTAL
Intervention: Force feedback
Number of subjects: 25
Study 24519025 — intervention group
Group type: COMPARATOR
Intervention: Time feedback
Number of subjects: 25
Study 22949664 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D
Number of subjects: 95
Study 22949664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 20399410 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated group discussions
Number of subjects: 64
Study 20399410 — intervention group
Group type: COMPARATOR
Intervention: Self-guided approach (newsletters)
Number of subjects: 64
Study 18928632 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-11 (25 microg/(kg.d) injected s.c. for 28 days)
Number of subjects: 26
Study 18928632 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional hormonal therapy and immunosuppressive therapy)
Number of subjects: 26
Study 16813184 — intervention group
Group type: EXPERIMENTAL
Intervention: Three phase acupuncture method
Number of subjects: 70
Study 16813184 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture method
Number of subjects: 70
Study 16813184 — intervention group
Group type: EXPERIMENTAL
Intervention: Difference in VAS after treatment between groups
Number of subjects: 70
Study 14663473 — intervention group
Group type: EXPERIMENTAL
Intervention: Periprostatic injection anesthesia with 10 cm3 (5 cm3 each side) 1% lidocaine
Number of subjects: 100